Imaging Endpoints Selects the OpenClinica EnterpriseTM to Accelerate Imaging Clinical Trials
Open Source software enhances speed and efficiency of imaging intensive clinical trials
Scottsdale, AZ (PRWEB) July 21, 2010
Akaza Research, LLC, the provider of the OpenClinica open source clinical trials software, today announced that Imaging Endpoints has selected the OpenClinica Enterprise Edition as the electronic data capture and data management platform for its clinical trials. Based in Scottsdale, Arizona, Imaging Endpoints is a medical imaging core lab that works to maximize the efficiency and quality of high stakes pharmaceutical and medical device trials. The company provides imaging core lab services for oncology, cardiovascular, neurology, and musculoskeletal studies.
"Critical to the success of our clients' trials, Imaging Endpoints relies on advanced software for electronic data capture and management. The OpenClinica Enterprise Edition allows us to accelerate our imaging clinical trials and provide the most efficient, reliable, cost-effective imaging studies in the fastest possible timeframes," said Alison Coates, Director of Imaging Endpoints.
The OpenClinica Enterprise Edition is the commercially supported version of the OpenClinica open source clinical trials software. It facilitates the collection of clinical trial data in distributed settings, provides transparency into trial progress, and has tools for ensuring data is clean, uniform, and can be readily analyzed. OpenClinica and associated support are provided by Akaza Research, LLC of Waltham, Massachusetts. For more information about OpenClinica product editions please visit http://www.openclinica.org/page.php?pid=550.
Akaza's professional open source model for OpenClinica provides high-impact benefits to OpenClinica Enterprise customers. Enhanced flexibility, ready access to data, and absence of "per-study" pricing are among key attributes of this model. The end result is that the customer has more control over set-up and use of the technology, allowing them to more rapidly deploy EDC and more easily tailor the system to meet requirements of specific studies.
Akaza Research CEO, Cal Collins, said, "Working with technology focused leaders like Imaging Endpoints is always a great experience because we understand the impact well-implemented EDC technology can have on clinical trial success. Together with Imaging Endpoints we can deliver highly capable, rapidly deployed, and cost effective clinical data capture and data management solutions for imaging clinical trials."
About Imaging Endpoints
As an imaging core lab specializing in clinical trials, Imaging Endpoints works to maximize the efficiency and quality of high stakes pharmaceutical and medical device trials. The company's superior process management accelerates clinical development by leveraging exclusive cutting-edge technology to speed up imaging study time and avoid costly errors. Backed by more than 25 years experience with its parent company, Imaging Endpoints' project managers and board-certified, fellowship-trained radiologists provide highly detailed service and unparalleled radiology expertise. For more information about Imaging Endpoints see http://www.imagingendpoints.com or call 480-314-3070.
About OpenClinica®
OpenClinica is open source, web-based clinical trials software for electronic data capture (EDC) and clinical data management (CDM). OpenClinica facilitates study protocol configuration, data collection via electronic case report forms (eCRFs), and enables productive clinical trials management. OpenClinica supports HIPAA, 21 CFR Part 11, and other regulator guidelines and is designed as a standards-based, extensible, and modular platform. The OpenClinica Community (free) and Enterprise (commercial) Editions provide a dramatically lower cost of ownership when compared with alternative proprietary technologies. For more information (including product downloads) visit www.openclinica.org or follow @OpenClinica on Twitter.
About Akaza Research®
Akaza Research is the provider of the leading open source clinical trial software, OpenClinica. Trusted by hundreds of biopharmaceutical companies, contract research organizations, academic, and government organizations worldwide, Akaza's professoinal open source model brings Open Source Software (OSS) into the mainstream of today's clinical research enterprise. The company provides commercial support to its OpenClinica customers across six continents servicing clinical studies of all types and sizes. For more information, visit http://www.akazaresearch.com.